Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.7150
-0.0100 (-1.38%)
Sep 11, 2026, 1:14 PM AEST
Orthocell Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 11.41 | 7.85 | 5.32 | 4.24 | 1.53 | |
Revenue Growth | 45.37% | 47.62% | 25.27% | 177.01% | 50.47% |
Cost of Revenue | 4.71 | 4.26 | 1.63 | 1.03 | 0.7 |
Gross Profit | 6.69 | 3.58 | 3.69 | 3.22 | 0.83 |
Selling, General & Admin | 18.04 | 9.48 | 6.7 | 5.96 | 5.54 |
Research & Development | 4.02 | 6.01 | 8.67 | 7.6 | 6.82 |
Other Operating Expenses | - | - | -0.42 | -0.06 | -0 |
Operating Expenses | 25.08 | 16.71 | 14.95 | 13.5 | 12.35 |
Operating Income | -18.38 | -13.13 | -11.26 | -10.28 | -11.52 |
Interest & Investment Income | 1.82 | 1.3 | 1.03 | 0.85 | 0.08 |
Earnings From Equity Investments | -0.1 | - | - | - | - |
Currency Exchange Gain (Loss) | -0.25 | 0.02 | - | 0.02 | 0.19 |
Other Non Operating Income (Expenses) | 3 | 3.25 | - | - | - |
EBT Excluding Unusual Items | -13.91 | -8.57 | -10.23 | -9.41 | -11.25 |
Pretax Income | -13.91 | -8.57 | -10.23 | -9.41 | -11.25 |
Income Tax Expense | - | - | -3.05 | -3.16 | -2.14 |
Net Income | -13.91 | -8.57 | -7.18 | -6.25 | -9.11 |
Net Income to Common | -13.91 | -8.57 | -7.18 | -6.25 | -9.11 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 263 | 223 | 202 | 197 | 195 |
Shares Outstanding (Diluted) | 263 | 223 | 202 | 197 | 195 |
Shares Change | 17.94% | 10.52% | 2.43% | 1.31% | 4.18% |
EPS (Basic) | -0.05 | -0.04 | -0.04 | -0.03 | -0.05 |
EPS (Diluted) | -0.05 | -0.04 | -0.04 | -0.03 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -13.85 | -8.94 | -7.43 | 13.98 | -6.78 |
Free Cash Flow Per Share | -0.05 | -0.04 | -0.04 | 0.07 | -0.04 |
Gross Margin | 58.67% | 45.66% | 69.39% | 75.82% | 54.13% |
Operating Margin | -161.15% | -167.35% | -211.92% | -242.28% | -752.21% |
Profit Margin | -121.98% | -109.17% | -135.10% | -147.26% | -594.53% |
Free Cash Flow Margin | -121.39% | -113.98% | -139.82% | 329.46% | -442.55% |
EBITDA | -17.78 | -12.76 | -10.91 | -9.93 | -11.3 |
EBITDA Margin | -155.83% | -162.56% | -205.25% | -233.91% | - |
D&A For EBITDA | 0.61 | 0.38 | 0.35 | 0.35 | 0.22 |
EBIT | -18.38 | -13.13 | -11.26 | -10.28 | -11.52 |
EBIT Margin | -161.15% | -167.35% | -211.92% | -242.28% | - |